Overview on the efficacy and safety of gadobutrol: an MRI contrast agent for the CNS, body and vessels

Autor:	Sara S. K. Koenig, Juan E. Gutierrez, Josy Breuer
Rok vydání:	2012
Předmět:	medicine.medical_specialty Radiological and Ultrasound Technology CONTRAST ENHANCED MRI business.industry MRI contrast agent Gadobutrol Gadolinium-based Contrast Agent medicine Radiology Nuclear Medicine and imaging Radiology Clinical imaging Mr images Nuclear medicine business medicine.drug
Zdroj:	Imaging in Medicine. 4:25-40
ISSN:	1755-5205 1755-5191
DOI:	10.2217/iim.11.70
Popis:	Contrast-enhanced MRI has become a mainstay of clinical imaging with unlimited applications. However, a limitation of conventional contrast agents in MRI is the insufficient signal-to-noise ratios due to relaxivity. Gadobutrol (1.0 mmol/ml), an extracellular macrocyclic contrast agent of high stability, is indicated for contrast-enhanced MRI of adults, adolescents and children 2 years of age and older. Gadobutrol offers increased T1 relaxivity, which improves MR image quality and clinical use of the technique.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5e68b0910483b9fa80cf5ef887b8ff68 https://doi.org/10.2217/iim.11.70 Zobrazit plný text záznamu